Tag: vaccine

Covid immunity strengthens over time in vaccinated people: Study
New Frontiers

Covid immunity strengthens over time in vaccinated people: Study

The human body's immunity to Covid-19 appears to gather strength with more time between vaccination and infection, a new study has shown. San Francisco, Jan 27 : The human body's immunity to Covid-19 appears to gather strength with more time between vaccination and infection, a new study has shown. According to US-based Oregon Health & Science University (OHSU) study, it suggests people, who have had Covid-19, have benefited from vaccination, even if they delayed it. In this study, researchers measured the immune response in blood samples for people, who gained hybrid immunity by either getting vaccinated before a breakthrough infection or by getting vaccinated after contracting Covid-19. The researchers measured the immune response in 96 generally healthy employees ...
Are Covid vaccines affecting the heart, inducing other non-communicable diseases?
New Frontiers

Are Covid vaccines affecting the heart, inducing other non-communicable diseases?

While the Covid-19 vaccines are saving lives, serious side effects, inducing inflammation in the heart, have been reported after vaccinations, along with other premature non-communicable diseases (NCDs). New Delhi, Jan 25 : While the Covid-19 vaccines are saving lives, serious side effects, inducing inflammation in the heart, have been reported after vaccinations, along with other premature non-communicable diseases (NCDs). However, new research now claims the reported adverse events are low in number. According to the WHO, more than 850 million cases and over 6.6 million deaths from Covid have been reported worldwide. Currently, the death rate has been reduced due to the decreased pathogenicity of new SARS-CoV-2 variants, but the major factor in the reduced death rates ...
First Made-in-India intranasal Covid vaccine to be launched on R-Day
New Frontiers

First Made-in-India intranasal Covid vaccine to be launched on R-Day

Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC on January 26, the company's CMD Krishna Ella announced here on Saturday. Bhopal, Jan 21 : Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC on January 26, the company's CMD Krishna Ella announced here on Saturday. The vaccine manufacturer had already received approval from the Central Drugs Standard Control Organisation (CDSCO) earlier this month for the nasal vaccine, the first of its kind in India. "Our nasal vaccine will be officially launched on Republic Day on January 26," said Ella while participating in a session during the 8th edition of the India International Science Festival (IISF) that began at the Maulana Azad National Institute of Technology (MANIT), here on Saturday. The...
Researchers working on Covid vaccine that people can drink
Medical Edge

Researchers working on Covid vaccine that people can drink

Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines. San Francisco, Jan 23 : Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines. The vaccine, called QYNDR, completed its phase 1 clinical trial and is currently waiting on more funding to conduct the more detailed, advanced trials that could actually bring the vaccine to market, reports CNET. "The QYNDR vaccine is pronounced 'kinder', because it's a softer way to deliver a vaccine," Kyle F...
US experimental HIV vaccine regimen safe but ineffective: Study
New Frontiers

US experimental HIV vaccine regimen safe but ineffective: Study

A US investigational HIV vaccine regimen was safe but did not provide protection against HIV acquisition, according to a statement of the US National Institute of Health (NIH). Los Angeles, Jan 19 : A US investigational HIV vaccine regimen was safe but did not provide protection against HIV acquisition, according to a statement of the US National Institute of Health (NIH). The trial, called HPX3002/HVTN 706 or "Mosaico," began in 2019 and involved 3,900 volunteers aged between 18 to 60 years in Europe, North America and South America, Xinhua news agency reported. The trial was conducted by the HIV Vaccine Clinical Trials Network funded by the US National Institute of Allergy and Infectious Diseases, based at the Fred Hutchinson Cancer Research Centre in Seattle. The expe...
UP gets fresh supply for Covishield vax doses
National News

UP gets fresh supply for Covishield vax doses

Uttar Pradesh has received a fresh supply of 42,700 Covishield vaccine doses after a gap of 13 days. Lucknow, Jan 18 : Uttar Pradesh has received a fresh supply of 42,700 Covishield vaccine doses after a gap of 13 days. The stock reached Uttar Pradesh Medical Supplies Corporation Limited from the Union government that released it immediately for vaccination. District immunization officer Dr M.K. Singh said: "With fresh supplies, Covid-19 vaccination will start from Wednesday at 34 centres, including KGMU, SGPGI and RMLIMS and 12 district hospitals and 19 urban and rural community health centres." He said that both advanced registration through online mode and walk-in registration facility will be available at the vaccination site. Candidates would have to carry a iden...
Vaccines or villains? Govt admits multiple side-effects of Covid-19 jabs in RTI reply
National News

Vaccines or villains? Govt admits multiple side-effects of Covid-19 jabs in RTI reply

It's official. The government's two top watchdogs have admitted to 'multiple side-effects' of Covid-19 vaccines that were jabbed in over a billion Indians in the past more than two years. Mumbai, Jan 16 : It's official. The government's two top watchdogs have admitted to 'multiple side-effects' of Covid-19 vaccines that were jabbed in over a billion Indians in the past more than two years. The startling revelations are made by the Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) in an RTI reply to Pune businessman Prafful Sarda. India has permitted AstraZenaca and Serum Institute of India, Pune's 'Covishield' and SII's own 'Covovax'; vaccines of three Hyderabad-based companies -- the government-run Bharat Biotech Ltd.'s 'Cova...
Explained: How India evaded current global Covid surge to date
National News

Explained: How India evaded current global Covid surge to date

As countries like China and Japan bear the maximum brunt of the global Covid surge, India has survived the immediate threat and according to health experts, majority of the population has got either natural immunity or vaccine-induced immunity to all coronavirus strains currently active in the country. New Delhi, Jan 13 : As countries like China and Japan bear the maximum brunt of the global Covid surge, India has survived the immediate threat and according to health experts, majority of the population has got either natural immunity or vaccine-induced immunity to all coronavirus strains currently active in the country. Given the exposure of the Omicron variant in India in the last one year, there is hardly any possibility of any significant public health problem to be caused ...
Covid vax acceptance up globally, young people hesitant about boosters
National News

Covid vax acceptance up globally, young people hesitant about boosters

The global acceptance of Covid-19 vaccines increased from 75.2 per cent in 2021 to 79.1 per cent in 2022, according to a survey in 23 countries (including India) that represent more than 60 per cent of the world's population. New Delhi, Jan 10 : The global acceptance of Covid-19 vaccines increased from 75.2 per cent in 2021 to 79.1 per cent in 2022, according to a survey in 23 countries (including India) that represent more than 60 per cent of the world's population. The willingness of parents to vaccinate their children also rose slightly, from 67.6 per cent in 2021 to 69.5 per cent in 2022. However, vaccine acceptance decreased in eight countries and almost one in eight vaccinated respondents, particularly younger men and women, were hesitant about receiving a booster dos...
Sri Lanka risks rapid spread of rabies due to vaccine shortage
Global News

Sri Lanka risks rapid spread of rabies due to vaccine shortage

Rabies might spread rapidly in Sri Lanka in 2023 due to shortages in vaccines, a health official said here on Wednesday. Colombo, Jan 4 : Rabies might spread rapidly in Sri Lanka in 2023 due to shortages in vaccines, a health official said here on Wednesday. Director of Public Health Veterinary Services L.D. Kithsiri told journalists that there were no vaccines in storage units in Kandy, Galle, Matara, Hambantota, Colombo, and Gampaha districts, reports Xinhua news agency. Twenty-eight people died last year from rabies and out of that 17 contracted the disease, Kithsiri said. "We are carrying out vaccination programs until February using the remaining vaccines in other regional storage units," he said, adding that there will be no vaccination from February. In 2022, t...